Case Study: Implementing comprehensive clinical exome analysis to support diverse applications at Henry Ford Health

Published on 10/09/2024

< 1 min read

See how Henry Ford Health enhanced their genetic testing by adopting exome sequencing for hereditary cancer, cystic fibrosis, and pharmacogenetics applications.

Discover how Henry Ford Health streamlined their genetic testing by moving from three separate assays to a single, powerful exome-based solution. Learn how the SOPHiA DDM Exome Solution v3 consolidated their workflows for hereditary cancer, cystic fibrosis, and pharmacogenetics, offering broad gene coverage with a compact assay footprint. Dive into the full story to see how this innovative approach enabled detection of SNVs, Indels, and CNVs in one comprehensive assay, simplifying their germline testing processes.

About the Author

Mallory Gough

Proposition and Content Marketing Senior Manager

Sign Up To Our Newsletter

Enter your email address to join our mailing list and receive the latest news and updates from SOPHiA GENETICS. You can unsubscribe by using the link integrated with the communication at any time. By clicking to “sign up”, you agree that SOPHiA GENETICS will process your data in accordance with its Privacy Policy

pink dots icon

Related Posts

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';